HL Huang Lab UT Health San Antonio and Mays Cancer Center

Spin-off companies

Programs translated beyond the lab bench.

The Huang Lab has built translational pathways that extend into venture-backed and product-focused companies designed to move promising science toward real-world use.

Powerhouse Therapeutics

A Huang Lab spin-out advancing PH102 and selected solid-tumor cell therapy programs toward the clinic.

Powerhouse Therapeutics was formed to translate Huang Lab discoveries into clinical-stage therapeutics, with an emphasis on oncology programs that emerged from the lab’s work in solid tumors and the tumor immune microenvironment.

Its initial portfolio includes PH102 and cell-therapy-related programs positioned for translational development, manufacturing readiness, and downstream partnering.

PH102solid-tumor cell therapytranslational development
Visit company

Abioremedi

A Huang Lab-affiliated company focused on translating innovative biological technologies into real-world impact.

Abioremedi represents the lab’s broader commitment to building translation pathways around promising science and product concepts.

The company section is structured so final brand assets, detailed program descriptions, and outbound links can be updated as materials are finalized.

biological technologytranslationcommercial development
Visit company